Specialty: Family Practice, Internal Medicine, Psychiatry, Pain Management, Oncology, Pediatrics

 In this section, you will find innovative genetic testing that can be used in multiple

medical fields, providing alternative therapies for your patient


Our laboratories' Clinical Health & Wellness Profiles provide valuable
insight to a patient's health and nutrition through their comprehensive
diagnostic profile.

The diagnostic profiles, which differ slightly for men and women, are an
important part of routine checkups or, if deemed medically necessary, 
an annual wellness visit.

Urinary Tract Infection is a very common bacteria I or fungal infection responsible for more than 15 million office and emergency room visits
each year in the United States.

We now offer a new solution from our labs to pathogen
detection in UTls,
Real-Time Polymerase Chain Reaction for Urinary Tract Microbiota (qPCR).

Using the latest molecular biology techniques and methods, our
laboratories are able to use the genetic material of the pathogen
(DNA, RNA) to accurately identify the species of the pathogen and to
detect resistance genes expressed by the pathogen to certain pharmacotherapies.

Verification data demonstrates qPCR is over 25% more accurate when
compared to traditional culture-based methods of detection.

Respiratory tract infections (RTls) are the most common, and potentially
most severe, of infections treated by health care practitioners. Lower RTls
along with influenza, are the most common cause of death by
infection in the United States. Identifying the causative pathogen(s)
rapidly and accurately is key in deciding on a proper treatment protocol.

We now offer a new solution from our labs to pathogen detection
in RTls,
Real-Time Polymerase Chain Reaction for Respiratory Tract Microbiota.

Using the latest molecular biology techniques, our laboratories are able
to use the genetic material of the pathogen (DNA, RNA) to accurately identify the
species of the pathogen.

Our laboratories uses state of the art laboratory technique and the most advanced technology available, LC-MS/MS (Liquid Chromatography Tandem Mass Spectrometry), to provide clear and accurate results with a rapid turnaround time.

Over 1 Million Americans are diagnosed with cancer each year. Of these
diagnoses, approximately 5% of the genesis of the cancer is contributed to
genetic factors. These hereditary cancers (which can include breast cancer,
ovarian cancer, colorectal cancer, lynch syndrome, and others). have in
common Cancer Predisposition Genes (CPGs) which are mutations passed
on from generation to generation.

Our lab's Hereditary Cancer Screen is able to detect the
presence of these CPGs. So, what does a positive result mean? A positive
result is not a diagnosis of cancer, nor does it mean that the patient will be
diagnosed with cancer. A positive result simply means that a patient is
genetically predisposed to a higher risk of being diagnosed with cancer
than the general population. Having this information in hand, a clinician
can be more diligent in the use of screening and detection techniques,
with the hope of an earlier detection.

Our lab's Pharmacogenetic Testing provides insight into a patient's
genetic propensity to experience a drug-to-drug interaction or to be
non-responsive with certain medication classes.
This information is invaluable to clinicians whether they are initiating therapy
or evaluating a patient's progress.

We evaluate 26 separate genes and over 120 variants to create an easy to
understand report on 15 drug classes and 182 pharmacologic agents.
This provides clinicians with one of the most robust reports in the industry
and will help guide the clinician's choices in pharmacotherapy.

Currently we offer Pharmacogenetic Testing Panels for
the following
medication classes:

• Cancer • Cardiovascular • Diabetes • Gastrointestinal• infectious Disease
• Neurology
Jim Pollak : CEO

© 2019 by Progress Medical LLC. Proudly created by Scenic Streams LLC